Navigation Links
Kronos Science Laboratories (KSL) Has Lost a Great Leader and a Good Friend, Dr. Chris Heward
Date:2/9/2009

PHOENIX, Feb. 9 /PRNewswire-USNewswire/ -- Kronos Science Laboratories (KSL) has lost a great leader and a good friend. Christopher B. Heward, Ph.D. died on January 10, 2009 after a stormy three month battle with an aggressive cancer of the esophagus. Dr. Heward was a dedicated gerontologist and a superb laboratory scientist. He completed a BA at the University of Arizona with dual majors in Chemistry and Psychology in 1972, and then stayed on an additional year to earn a BS in Biology. Chris went on to graduate school at the same institution and was awarded an MS in Anatomy in 1977 and a Ph.D. in Biology in 1981, with his thesis work on the endocrine actions of melatonin and related peptides.

Dr. Heward's primary responsibility with KSL was to provide scientific and technical leadership for the laboratory activities. Chris brought to all his endeavors an astounding keenness of intellect and a broad-ranging interest in how things work. He was a consummate skeptic, with an incredibly sensitive nose for B.S. Chris loved a good debate; controversy was his metier. His watchword was, "Show me the data," which he would then mercilessly dissect. There was no possibility of slipping shoddy work or faulty thinking past Dr. Chris Heward. Yet, he was also an enthusiast. His excitement and commitment were infectious, consistently motivating those he supervised as well as his peers and collaborators to push harder and try new approaches.

No description of Chris would be complete without mention that, as busy as he was, he was also a loving husband and good friend to his wife Pam and the proud active father of five children, an adult son and daughter, a second daughter in college, and two younger boys, one in high school and the other in middle-school. Chris was never more himself than when at home relaxing with family and friends. He truly knew how to have a good time.

Mr. Jonathan Thatcher, CEO of KSL stated, "Chris led a busy, productive, and happy life. As we celebrate Chris' life, we will continue his legacy. In lieu of flowers, the family requests that donations be made to the Chris Heward Memorial Fund at Kronos Longevity Research Institute. Contributions will continue Dr. Heward's work in diseases prevention and early detection research. For donation online visit www.kronosinstitute.org and note Chris Heward Memorial Fund in the comments or call (866) 840-1117.

About Kronos Science Laboratory

Kronos Science Laboratory is dedicated to the discovery and implementation of innovative new technologies for the improvement of human health and longevity. KSL's contract research and diagnostic product development expertise ensure that best in class central and specialty laboratory services are delivered to clients and collaborators. Kronos' assay menu includes many internally-developed biomarkers of oxidative stress. For information about KSL, please visit www.kronoslaboratory.com.


'/>"/>
SOURCE Kronos Science Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kronos Optimal Health Company Aims to Stop Diabetes Before It Starts
2. SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement
3. GBC Seeks Nominations for Fourth Annual Bioscience Awards
4. Cardiac Science Increases R&D Capacity With 3-year Syncroness Agreement
5. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
6. Prescription Drugs: Good Medicine - Bad Behavior; Science Matters Program Explores the Rise in Prescription Drug Abuse Presented by the California Science Center
7. Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas
8. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
9. Grossology Exhibit Captivates Kids at The Orlando Science Center
10. UNT Health Science Center Researchers Discover Eating Less May Not Increase Life Expectancy
11. Introducing HEAL-WA--New Initiative Brings Evidence-Based Health Sciences Information to Health Professionals in Washington State
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners ... as their value increases in the healthcare workforce, according to a survey recently ... boards, career fairs, and candidate leads to healthcare employers of physicians and advanced ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Israel , March 28, 2017 Emosis ... This new business entity, Emosis Ltd, headquartered in Tel ... of novel assays complementing the mother company existing technology platform and ... and sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. ...
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: